2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
Cardiac fibrosis
NG Frangogiannis - Cardiovascular research, 2021 - academic.oup.com
Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of
extracellular matrix proteins, is a common pathophysiologic companion of many different …
extracellular matrix proteins, is a common pathophysiologic companion of many different …
[HTML][HTML] Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for …
Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …
The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis
Significance: Fibrosis is the endpoint of chronic disease in multiple organs, including the
skin, heart, lungs, intestine, liver, and kidneys. Pathologic accumulation of fibrotic tissue …
skin, heart, lungs, intestine, liver, and kidneys. Pathologic accumulation of fibrotic tissue …
Fibrosis—a common pathway to organ injury and failure
DC Rockey, PD Bell, JA Hill - New England Journal of Medicine, 2015 - Mass Medical Soc
Fibrosis — A Common Pathway to Organ Injury and Failure | NEJM Skip to main content NEJM
Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …
Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …
T1 mapping: basic techniques and clinical applications
In cardiac magnetic resonance (CMR) imaging, the T1 relaxation time for the 1H
magnetization in myocardial tissue may represent a valuable biomarker for a variety of …
magnetization in myocardial tissue may represent a valuable biomarker for a variety of …
Empagliflozin ameliorates diastolic dysfunction and left ventricular fibrosis/stiffness in nondiabetic heart failure: a multimodality study
CG Santos-Gallego, JA Requena-Ibanez… - Cardiovascular …, 2021 - jacc.org
Objectives The purpose of this study was to investigate the effect of empagliflozin on
diastolic function in a nondiabetic heart failure with reduced ejection fraction (HFrEF) …
diastolic function in a nondiabetic heart failure with reduced ejection fraction (HFrEF) …
T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure
VO Puntmann, G Carr-White, A Jabbour, CY Yu… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The study sought to examine prognostic relevance of T1 mapping parameters
(based on a T1 mapping method) in nonischemic dilated cardiomyopathy (NIDCM) and …
(based on a T1 mapping method) in nonischemic dilated cardiomyopathy (NIDCM) and …
Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy
Background: Heart failure (HF) is a state of inappropriately sustained inflammation,
suggesting the loss of normal immunosuppressive mechanisms. Regulatory T-lymphocytes …
suggesting the loss of normal immunosuppressive mechanisms. Regulatory T-lymphocytes …
[HTML][HTML] T1-mapping in the heart: accuracy and precision
The longitudinal relaxation time constant (T1) of the myocardium is altered in various
disease states due to increased water content or other changes to the local molecular …
disease states due to increased water content or other changes to the local molecular …